Skip to content

Dr. David Degrauwe

Active
Private limited companyfounded 2023active for 3 yearsVillerslei 2, 2900 Schoten, BelgiumKBO/BCE: BE 1000.983.184
Summary

Dr. David Degrauwe has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €120,558 and a net result of €56,173. Its solvency ranks better than 42% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Overview

Official details

Source: KBO
Status
Active since 10-10-2023 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.350.883.882 2900 Schoten, since 10-10-2023
Financial year end
31 December
Peppol
Reachable since 04-09-2024

Board and ownership

Board

Financial position

91 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Annual accounts 2025
Gross margin
€91,643
▲ 8.7%
Turnover
≈ €210,000
estimated
Profit
€56,173
▼ 10.9%
Equity
€120,558
▲ 84.9%
Total assets
€223,377
▲ 170%
  • 2025 accounts filed 14 days after the deadline
Filed on 14-08-2026
Score breakdownraises risk1 change of registered office in 24 monthsFounded in 2023lowers riskSector: Human health activities (NACE 86)Figures for financial year 2025 (filed on 15-08-2026)Show the evidence

Checked score

Score 2025
91 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 64% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 79-21
equity 54.0% of total assets
Liquidity 66-31
short-term debt 6.0% · cash 12.6%
Profitability 100=
return on assets 25.1%
Bankruptcy probability within 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: 0.3% 01-2025: 0.6%▲ +0.3 percentage points vs 12-2024 02-2025: 0.6%● unchanged vs 01-2025 03-2025: 0.6%● unchanged vs 02-2025 04-2025: 0.7%▲ +0.1 percentage points vs 03-2025 05-2025: 0.7%● unchanged vs 04-2025 06-2025: 0.8%▲ +0.1 percentage points vs 05-2025highest value 07-2025: 0.7%▼ -0.1 percentage points vs 06-2025 08-2025: 0.7%● unchanged vs 07-2025 09-2025: < 0.1%▼ -0.7 percentage points vs 08-2025lowest value 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: 0.1%▲ +0.1 percentage points vs 02-2026 04-2026: 0.1%● unchanged vs 03-2026 05-2026: 0.1%● unchanged vs 04-2026 06-2026: 0.1%● unchanged vs 05-2026 07-2026: 0.1%● unchanged vs 06-2026 08-2026: 0.2%▲ +0.1 percentage points vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026 11-2026: 0.2%● unchanged vs 10-2026
Credit of up to €10,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 5.36 (5.61 in 2024), above the usual 1.5. Short-term debt is 6% and cash 12.6% of total assets. 46% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 43% of them on solvency, 45% on liquidity, 80% on profitability and 88% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
raises risk · Founded in 2023
Companies of this age fail more often than older ones. How much that weighs depends on the rest of the company's profile.
KBO
lowers risk · Figures for financial year 2025 (filed on 15-08-2026)
NBB · annual accounts
raises risk · 2025 accounts filed 14 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 14-08-2026, 14 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 2 filings
Deviation from the deadline
2025
14 days late
2024
18 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 2 accounts on average 16 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2023.
KBO publications

Key points

  • Positive: Equity rose in 2025from €65,217 to €120,558 ▲ 84.9% View

Recent changes

  1. · Gazette deed Registered office moved from Lint to Schoten
  2. · Gazette deed IncorporationStarting capital €3,000 · Appointment: Degrauwe, David Mikhaël Maria (director)
All 5 events

Comparable companies

These companies have the same main activity as Dr. David Degrauwe: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €201,000 and €234,000, founded in 2023.

CompanyTotal assetsGross margin
Dr. David Degrauwe Schoten€223,377€91,643
Em. Prof. Dr. Patrick Cras Antwerpen€212,941€92,161
Dr. M. Denis Mortsel€203,838€100,031
Dr. WYBAILLIE Elke Wervik€233,876€85,996
DERMATODEL Vorst€205,813€98,251
Dr. Claes Marleen Lubbeek€230,670€81,188
Health & Beauty Clinic Lasne€200,564€99,937
Full comparison

Key facts about Dr. David Degrauwe

What is the company number of Dr. David Degrauwe?
The company number of Dr. David Degrauwe is 1000.983.184. The VAT number is the same number with BE in front: BE 1000.983.184.
Where is Dr. David Degrauwe based?
The registered office is at Villerslei 2, 2900 Schoten.Company details
What does Dr. David Degrauwe do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. David Degrauwe?
The legal form of Dr. David Degrauwe is Private limited company (BV).
When was Dr. David Degrauwe founded?
Dr. David Degrauwe was founded on 10-10-2023.
Is Dr. David Degrauwe still active?
Yes, Dr. David Degrauwe is an active enterprise in the KBO register.
What is the turnover of Dr. David Degrauwe?
The turnover in financial year 2025 is ≈ €210,000. This figure is estimated from the gross margin of €91,643 and 32 comparable companies (NACE 862). It probably lies between €160,000 and €260,000.Financials
Is Dr. David Degrauwe profitable?
In financial year 2025, Dr. David Degrauwe made a profit of €56,173.
Where can I find the annual accounts of Dr. David Degrauwe?
Dr. David Degrauwe filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. David Degrauwe due?
Dr. David Degrauwe must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.